A cutting-edge cancer treatment labelled as a “total paradigm shift” is about to be released in Australia, with the hopes it will improve the health of those suffering from the most aggressive forms of the disease.

CAR T-cell therapy is expected to soon be approved by the Therapeutic Goods Administration for conditions like leukemia and myeloma.

Director of the Centre of Excellence in Cellular Immunotherapy Professor Simon Harrison told Gary Adshead on 6PR Mornings the treatment is set to be the future of cancer therapy.

Press PLAY to hear more about the pioneering treatment